Lisanti Capital Growth, LLC Dexcom Inc Transaction History

Lisanti Capital Growth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $346,996 - $583,162	-5,536 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $5,352 - $8,470	-112 Reduced 1.98%	5,536 $1.49 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $206,829 - $323,573	5,648 New	5,648 $1.24 Million
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $470,312 - $639,705	-16,755 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$26.99 - $37.37 $46,827 - $64,836	1,735 Added 11.55%	16,755 $2.01 Million

Q3 2018 Nov 05, 2018	SELL	$23.35 - $36.72 $44,715 - $70,318	-1,915 Reduced 11.31%	15,020 $2.15 Million
Q2 2018 Aug 13, 2018	BUY	$17.54 - $25.22 $90,418 - $130,009	5,155 Added 43.76%	16,935 $1.61 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $153,846 - $218,401	11,780 New	11,780 $874,000

1,124

353M

4.19M

4.54M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.